Citigroup exec cashed $157M in options
Article Abstract:
Citigroup co-CEO Sanford Weill has exercised his stock options which amounted to $156.6 million in 1998. Citigroup's other co-CEO John Reed has $70 million in exercisable options which he did not realize in 1998. Reed's salary was $1.7 million and a bonus of $7.9 million. While the proxy recognized Reed and Weill's leadership in the successful merger of Citicorp and Traveler Group, it also mentions Citigroup's 'disappointing earnings.'
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Offbeat majors help CEOs think outside the box
Article Abstract:
This article discusses the varying educational backgrounds of CEOs of major American corporations. Only one third of the leaders of the country's 1,000 leading companies have MBA degrees and many have used liberal arts training to prepare them for their careers.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
GE enters new era as a legend leaves
Article Abstract:
The article discusses the new era General Electric (GE) is entering with its new CEO Jeffrey Immelt, who may be tougher than was originally thought.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Synergy equity fund tops competition. Civil servants price the cost of job leaves. Fund watch: Universal bucks precious metals trend
- Abstracts: WestJet steps up expansion plans. Air Canada overhaul: new fares, fewer frills. Jetsgo adds routes, slashes fares
- Abstracts: Trouble in paradise. Overinflate at your peril. Living well in the danger zone
- Abstracts: Miriam Dixson. Dale Spender: digital educator. Noel Pearson
- Abstracts: Partners' dispute hits Angiotech shares. Angiotech kills plan for options